2018
Jensen IS , Wu E, Cyr PL , Claussen M, Winkler T, Salhuddin K, Prats J, et al. Cost-consequence analysis of using cangrelor in high angiographic risk percutaneous coronary intervention (PCI) patients: A US hospital perspective. Transcatheter Cardiovascular Therapeutics (TCT), San Diego, CA, 2018.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Hathway J, Purdum AG, Lin VW, Cyr PL , Westin J, Jensen IS . A budget impact model of Axicabtagene Ciloleucil in a US population of patients with relapsed/refractory large B-cell lymphoma (RR-LBCL). European Blood and Marrow Transplantation Meeting, Lisbon Portugal, 2018.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Ludden T, Ermakova A, Xiong Y, Cyr PL , Sieradzan R, Sacks NC , Taylor SD. Comparison of healthcare resource utilization for multiple-daily injections (MDI) with basal and bolus insulin therapy versus non-MDI therapy in patients with Type 2 diabetes. Poster presentation at Academy of Managed Care Pharmacy Annual Research Meetings, Boston, MA, 2018.
Publication: Abstracts and Presentations
/ Topics: diabetes , Health Economics and Outcomes Research (HEOR)
Ludden T, Ermakova A, Xiong Y, Cyr PL , Sieradzan R, Sacks NC , Taylor SD. Comparison of healthcare resource utilization and clinical status among Type 2 diabetes patients using multiple-daily injection (MDI) insulin therapy vs. non-MDI therapy. ISPOR 23rd Annual Conference, Baltimore MD, 2018.
Publication: Abstracts and Presentations
/ Topics: diabetes , Health Economics and Outcomes Research (HEOR)
Sacks NC , Cyr PL , Bariahtaris S, Sharma A, Everson K, Douville P, Ruskin J. Healthcare resource use and expenditures in patients under 65 years of age and newly diagnosed with paroxysmal superventricular tachycardia (PSVT) in the United States. Podium Presentation at World Congress on Heart Disease, Boston MA, 2018.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Sacks NC , Sharma A, Cyr PL , Bertiger G, Dahdal DN, Brogadir S. Real-world evidence comparison of the efficacy and safety of different bowel preparation agents in patients with inflammatory bowel disease. Digestive and Disease Week, Washington DC, 2018.
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Hathway J, Purdum AG, Lin VW, Cyr PL , Westin J, Jensen IS . A budget impact model of axicabtagene ciloleucel (Axi-cel) in an US population of patients with relapsed or refractory large b-cell lymphoma (RR-LBCL). Podium presentation at ISPOR 23th Annual International Meeting, Baltimore MD, 2018.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Sacks NC , Sharma A, Cyr PL , Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world evidence comparison of the efficacy and safety of different bowel preparation agents in a high-risk population. Gastroenterol 154(6) S632-S633; doi: 10.1016/S0016-5085(18)32266-2 .
View Abstract
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Sacks NC , Sharma A, Cyr PL , Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world comparison of the effectiveness and safety of different bowel preparation agents. Clin Exp Gastroenterol 11:289–299; doi: 10.2147/CEG.S171861 .
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology
Sacks NC , Cyr PL , Louie AC, Liu Y , Chiarella MT, Sharma A, Chung KC. 2018. Burden of acute myeloid leukemia among older, newly diagnosed patients: Retrospective analysis of data from the 2010-2012 Medicare limited data set. Clin Ther 40(5):692–703.e2; doi: 10.1016/j.clinthera.2018.03.012 .
View Abstract
A Division of